Cognizant Technology Solutions Earnings Call Transcripts
Fiscal Year 2026
-
2026 growth is projected at 4%-6.5%, driven by market share gains, large deals, and AI adoption. BFSI and healthcare lead sector growth, while BPO and fixed price contracts contribute to profitability. AI projects are scaling, and margin expansion is targeted through productivity and SG&A leverage.
Fiscal Year 2025
-
Revenue grew 6.4% year-over-year in constant currency, surpassing $21B, with strong large deal momentum and adjusted EPS up 11%. AI-driven productivity and innovation fueled growth across segments, and 2026 guidance projects continued top-tier performance.
-
Q3 2025 saw 6.5% revenue growth, margin expansion, and strong AI-driven deal momentum. All segments grew organically, with financial services and BPO leading. Guidance for full-year revenue and EPS was raised, and capital returns remain robust.
-
Financial services are shifting from cost optimization to innovation, with AI-driven productivity enabling both client savings and internal margin expansion. Agentic cycles and BPO are key growth drivers, while M&A focuses on diversifying industry exposure and building proprietary IP.
-
AI is driving transformation in IT services, with current focus on productivity but larger growth expected as clients industrialize and agentify AI. Financial Services is rebounding, Healthcare remains strong, and expansion into under-penetrated markets and platforms is underway. Strategic M&A and evolving pricing models support future growth.
-
Q2 2025 saw 7.2% revenue growth, margin expansion, and strong bookings, driven by AI-led deals and innovation. Guidance for 2025 was raised, with robust capital returns planned and continued momentum across all segments and regions.
-
Three mega deals were signed this year, with AI as a key differentiator and healthy deal momentum. Revenue and margin guidance already reflect these wins, while sector trends show BFSI leading discretionary spend and manufacturing/retail cautious due to policy uncertainty.
-
The organization has recalibrated its culture and processes, leading to renewed client and employee satisfaction. Large and mega deal activity has accelerated, driven by AI-powered transformation initiatives, with financial services showing positive momentum and other verticals remaining cautious or stable. Clients are increasingly receptive to AI-driven productivity and evolving pricing models.
-
The meeting highlighted strong financial growth, strategic investments in AI and talent, and robust shareholder returns. All board proposals passed except the shareholder proposal on special meeting rights, and leadership addressed questions on tariffs, employee distribution, and compensation.
-
Leadership highlighted deep customer focus, a strong deal pipeline, and AI-driven productivity as key differentiators. Despite sector uncertainty, large deals and digital engineering are driving growth, with ongoing investment in talent and margin expansion.
-
Q1 2025 saw 8.2% revenue growth and margin expansion, driven by health sciences, financial services, and Belcan. Despite April's macro uncertainty, guidance remains strong, with robust bookings, AI-led productivity, and a healthy cash position supporting continued investment and shareholder returns.
-
Aims to be a top-tier IT services provider by 2027, leveraging $1B+ AI investments, platform expansion, and a robust partner ecosystem. Achieved strong revenue and margin growth, with large deal momentum and a focus on operational excellence and talent innovation.
Fiscal Year 2024
-
Q4 revenue grew 6.7% year-over-year, led by Health Sciences and Financial Services, with strong large deal momentum and improved margins. 2025 guidance calls for 2.6%-5.1% revenue growth, margin expansion, and continued AI-driven innovation, supported by strategic acquisitions and robust bookings.
-
Significant leadership and structural changes have positioned the company for growth, with major investments in AI and engineering services. AI is driving both operational efficiency and new market opportunities, while improved margins and strong deal momentum support a positive outlook for 2025.
-
Q3 2024 saw revenue and earnings growth, margin expansion, and strong large deal momentum, led by Health Sciences and Financial Services. AI initiatives and acquisitions like Belcan are driving productivity and new business, with full-year guidance raised for EPS and revenue.
-
Leadership has driven a turnaround with a focus on growth, client trust, and employee morale, supported by investments in sales, GenAI, and new verticals. The Belcan acquisition and NextGen cost program are enhancing capabilities and efficiency, while AI initiatives are expected to drive future growth and margin improvement.
-
Revenue and margins exceeded guidance, with strong large deal momentum and improved performance in financial services and health sciences. Guidance for full-year revenue and EPS was raised, while the Belcan acquisition is set to expand ER&D capabilities. Market conditions remain challenging but stable.
-
The acquisition expands access to the fast-growing ER&D market, especially in aerospace and defense, and is expected to deliver over $100M in annual revenue synergies within three years. The deal, valued at $1.29B, will be accretive to EPS by 2026 and positions the company for long-term growth and diversification.
-
The meeting reviewed strong Q1 2024 results, strategic progress in talent and AI, and continued operational simplification. All board nominees and company proposals passed, while a shareholder proposal on board nominee treatment was rejected.